Tag: Prescription Drugs
New Malaria Treatment Gets First Approval for Use in Children
Single dose of tafenoquine is for use in combination with the traditional malaria drug chloroquine
Adding Ribociclib to Letrozole Prolongs Survival in Advanced Breast Cancer
Reduced risk for death seen with letrozole plus ribociclib versus placebo in postmenopausal women with HR-positive, HER2-negative disease
Nonantibiotic Prophylaxis Noninferior for Recurrent UTI
Incidence of antibiotic-treated UTI during 12-month treatment period noninferior for methenamine hippurate versus prophylactic antibiotics
Pfizer Begins Trial of COVID-19 Drug Paxlovid in Children 6 to 17 Years
Trial will assess safety and efficacy in children with confirmed infection who are not hospitalized but are at risk for severe disease
Molnupiravir for Nonsevere COVID-19 Added to Living Guideline
Molnupiravir recommended only for those at highest risk for hospitalization given its potential long-term harms
Nirsevimab Protects Against RSV in Late-Preterm, Term Infants
Single injection administered before RSV season protects from medically attended RSV-associated lower respiratory tract infection
AAN Issues Review of Evidence for Aducanumab in Alzheimer Disease
Class I study shows single doses of aducanumab safe, well tolerated; class II studies show reduced amyloid deposition on brain PET at one year
Overdose Deaths From Non-BZD Hypnotics/Sedatives Up in the U.S.
Proportion of overdose deaths involving these drugs increased more than threefold between 2000 and 2018
ACP Issues Final Practice Points for Remdesivir Use in COVID-19
Consider treatment with remdesivir for five days for hospitalized COVID-19 patients who do not require invasive ventilation or ECMO
AAAAI: Add-On Inhaled Glucocorticoid Lowers Severe Asthma Exacerbations
Adding inhaled glucocorticoid to usual care beneficial for Black and Latinx adults with moderate-to-severe asthma